Tumor necrosis factor-α and its receptors in epithelial ovarian cancer

被引：19
|
作者：
Dobrzycka, Bozena [1 ]
Terlikowski, Slawomir J. [1 ]
Garbowicz, Magdalena [2 ]
Niklinska, Wieslawa [3 ]
Bernaczyk, Piotr S. [4 ]
Niklinski, Jacek [2 ]
Kinalski, Maciej [5 ]
Chyczewski, Lech [4 ]
机构：
[1] Med Univ Bialystok, Dept Obstet Gynecol & Obstet Gynecol Care, PL-15062 Bialystok, Poland
[2] Med Univ Bialystok, Dept Clin Mol Biol, PL-15062 Bialystok, Poland
[3] Med Univ Bialystok, Dept Histol & Embryol, PL-15062 Bialystok, Poland
[4] Med Univ Bialystok, Dept Pathomorphol, PL-15062 Bialystok, Poland
[5] Dist Hosp, Dept Gynecol, Bialystok, Poland
来源：
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA | 2009年 / 47卷 / 04期
关键词：
tumor necrosis factor-alpha (TNF-alpha); tumor necrosis factor receptor 1 (TNF-R1); tumor necrosis factor receptor 2 (TNF-R2); epithelial ovarian cancer (EOC); TNF-ALPHA; BENIGN; SERUM; INFLAMMATION; HYPERPLASIA; PROGRESSION; EXPRESSION;
D O I：
10.2478/v10042-008-0117-1
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The aim of the present study was to characterize the expression pattern of tumor necrosis factor (TNF)-alpha and its receptors (TNF-Rs) in the epithelial ovarian cancer (EOC) and compare these results with the outcome of 126 patients. Presence of TNF-alpha, TNFR-1 and TNFR-2 were studied by Western blotting and immunohistochemistry. The proportion of samples positive for TNF-alpha and TNF-R2 was higher in epithelial ovarian cancer patients than in benign ovarian diseases (p<0.001 and p=0.016, respectively). Immunostaining intensity of TNF-R2 were correlated with tumor stage (p<0.001) and with reduced mean survival time (MST) (p=0.002). The results of the present study suggested that tissue expression of TNF-R2 in epithelial ovarian cancer was correlated with the highest risk of cancer progression. Thus, the clinical value of activated TNF system in epithelial ovarian cancer needs to be further investigated.
引用
收藏
页码：609 / 613
页数：5
相关论文
共 50 条
  • [1] Functionality of intrinsic disorder in tumor necrosis factor-α and its receptors
    Uversky, Vladimir N.
    Abd El-Baky, Nawal
    El-Fakharany, Esmail M.
    Sabry, Amira
    Mattar, Ehab H.
    Uversky, Alexey V.
    Redwan, Elrashdy M.
    FEBS JOURNAL, 2017, 284 (21) : 3589 - 3618
  • [2] Soluble tumor necrosis factor receptors and CA 125 in serum as markers for epithelial ovarian cancer
    Onsrud, M
    Shabana, A
    Austgulen, R
    TUMOR BIOLOGY, 1996, 17 (02) : 90 - 96
  • [3] The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells
    Kulbe, Hagen
    Thompson, Richard
    Wilson, Julia L.
    Robinson, Stephen
    Hagemann, Thorsten
    Fatah, Rewas
    Gould, David
    Ayhan, Ayse
    Balkwill, Frances
    CANCER RESEARCH, 2007, 67 (02) : 585 - 592
  • [4] The role of tumor necrosis factor-α receptors in atherosclerosis
    LeBoeuf, RC
    Schreyer, SA
    TRENDS IN CARDIOVASCULAR MEDICINE, 1998, 8 (03) : 131 - 138
  • [5] Tumor necrosis factor-α related gene response to Epothilone B in ovarian cancer
    Khabele, D
    Lopez-Jones, M
    Yang, WC
    Arango, D
    Gross, SJ
    Augenlicht, LH
    Goldberg, GL
    GYNECOLOGIC ONCOLOGY, 2004, 93 (01) : 19 - 26
  • [6] Possible actions of tumor necrosis factor-α in ovarian function
    Sakumoto, R
    Okuda, K
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2004, 50 (01): : 39 - 46
  • [7] The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines
    Kost, ER
    Herzog, TJ
    Adler, LM
    Williams, S
    Mutch, DG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 145 - 153
  • [8] Circadian fluctuations of melatonin, tumor necrosis factor-α and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer
    Muc-Wierzgon, M
    Nowakowska-Zajdel, E
    Zubelewicz, B
    Wierzgon, J
    Kokot, T
    Klakla, K
    Szkilnik, R
    Wiczkowski, A
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (02) : 171 - 178
  • [9] Tumor necrosis factor-α in the pathogenesis and treatment of cancer
    Anderson, GM
    Nakada, MT
    DeWitte, M
    CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) : 314 - 320
  • [10] Tumor Necrosis Factor-α and Its Receptors 1 and 2 Yin and Yang in Myocardial Infarction?
    Schulz, Rainer
    Heusch, Gerd
    CIRCULATION, 2009, 119 (10) : 1355 - 1357
12345